HIF-1α and cancer-associated fibroblasts (CAFs)-secreted TGF-β2 activate the expression GLI2 in CSCs, resulting in increased stemness/dedifferentiation and intrinsic resistance to chemotherapy. The gene discussed is GLI2; the disease is cancer.